RecruitingPhase 2NCT06590896

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

A Phase 2, Multicenter Open-Label Extension Study to Evaluate the Long-term Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Sponsor

Ono Pharmaceutical Co., Ltd.

Enrollment

100 participants

Start Date

Nov 4, 2022

Study Type

INTERVENTIONAL

Conditions

Epilepsies, Partial

Summary

To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Cenobamate for people with epilepsies, partial. The study is currently recruiting participants at 29 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCenobamate

Cenobamate will be orally administered once daily.

Locations(29)

Ehime University Hospital

Ehime, Japan

Department of Neurology and Stroke Center, Southern Tohoku Clinic.

Fukushima, Japan

Hiroshima University Hospital

Hiroshima, Japan

NHO Kure Medical Center and Chugoku Cancer Center

Hiroshima, Japan

Asahikawa Medical University Hospital

Hokkaido, Japan

Itami City Hospital

Hyōgo, Japan

JA-Ibaraki Tsuchiura Kyodo General Hospital

Ibaraki, Japan

University of Tsukuba Hospital

Ibaraki, Japan

Kagoshima University Hospital

Kagoshima, Japan

Tanaka Neurosurgical Clinic

Kagoshima, Japan

St. Marianna University School of Medicine Hospital

Kanagawa, Japan

Yokohama City University Hospital

Kanagawa, Japan

Kumamoto Ezuko Rehabilitation Medical Center

Kumamoto, Japan

NHO Nagasaki Medical Center

Nagasaki, Japan

Koide Clinic of Epilepsy and Neurological Disorders

Osaka, Japan

Osaka University Hospital

Osaka, Japan

Shintokukai Nii Neurosurgery and Psychiatry Clinic

Osaka, Japan

Ochiai Brain Clinic

Saitama, Japan

TMG ASAKA Medical Center

Saitama, Japan

Sakurai Clinic

Shiga, Japan

NHO Shizuoka Institute of Epilepsy and Neurological Disorders

Shizuoka, Japan

Seirei Hamamatsu General Hospital

Shizuoka, Japan

Seirei Mikatahara General Hospital

Shizuoka, Japan

Jichi Medical University Hospital

Tochigi, Japan

Tokushima University Hospital

Tokushima, Japan

Medical Hospital, Tokyo Medical and Dental University

Tokyo, Japan

National Center of Neurology and Psychiatry

Tokyo, Japan

Tokyo Medical University Hospital

Tokyo, Japan

NHO Yamagata National Hospital

Yamagata, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06590896

Related Trials

High-resolution Multi-parametric Magnetic Resonance Imaging for Focal Epilepsy

NCT065507261 location

A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures

NCT069670121 location

Treating Postictal Symptoms Using Ibuprofen and Nifedipine

NCT039494782 locations